Skin grafting

Skin grafting is a specialized surgical procedure used to transplant skin tissue. This process is vital for treating extensive wounding, such as trauma burns. It is also used to treat skin loss caused by infections like necrotizing fasciitis. Surgeons also use grafting to help areas heal after removing skin cancers. A skin graft is a piece of tissue moved to a new location. This helps reduce hospital time and improves the function of the body. It also helps the area look better after an injury.

The healing process follows a specific biological sequence. First, the graft undergoes plasmatic imbibition during the first 24 hours. In this stage, the graft "drinks" plasma to absorb nutrients from the recipient bed. Between two and three days, capillary inosculation begins. This is when new blood vessels grow from the recipient area into the graft. Finally, neovascularization occurs between four and seven days. This stage involves the formation of new blood vessels between the graft and the recipient tissues. To help this, doctors may use negative pressure wound therapy. This system uses a vacuum to draw out excess fluids and promote vessel growth.

Grafts are classified by their thickness and their source. A split-thickness skin graft (STSG) includes the epidermis and part of the dermis. These are common because they can cover large areas. Surgeons can use a machine called a mesher to create holes in the graft. This allows the tissue to expand up to nine times its original size. A full-thickness graft includes the epidermis and the entire dermis. These are used for the face or hands to minimize contraction and deformity. There are also composite grafts. These are small grafts that contain skin along with underlying cartilage or other tissue.

Sources for these grafts are categorized into five distinct types. An autograft, or autologous graft, comes from a different site on the same person. An isograft comes from genetically identical individuals, such as monozygotic twins. An allograft, or allogeneic graft, comes from a donor of the same species. A xenograft, or xenogeneic graft, comes from a different species, such as pig skin. Finally, a prosthetic graft uses synthetic materials like plastic or ceramic. Autologous grafts are usually permanent. Allografts and xenografts are often used as temporary dressings to prevent infection.

The history of skin grafting stretches back to ancient times. The Ebers Papyrus from ancient Egypt contains notes on xenografting. In the 2nd century AD, the philosopher Celsus used grafts for reconstructive surgery. Modern techniques emerged in the 19th century. In 1869, Reverdin used the pinch graft. In 1872, Ollier used split-thickness grafts. Thiersch developed split-thickness methods in 1886. Wolfe and Krause used full-thickness grafts in 1875 and 1893. In 1880, John Harvey Girdner demonstrated grafts from deceased donors.

There are several risks associated with these surgical procedures. Patients may face bleeding or infections at the site. There is also a risk of nerve damage or the loss of the grafted skin. In some cases, graft-versus-host disease can occur. Rejection is a major concern for xenografts. To prevent this, recipients may need long-term immunosuppressant drugs. Recovery can be a long process for the patient. Recipients often wear compression garments for several months. They may also face anxiety or depression due to long-term pain.

New technologies are constantly being tested to improve skin replacement. Scientists are researching cell cultured epithelial autografts (CEA). This involves growing a person's own skin cells into sheets in a laboratory. These sheets are very thin and can be fragile. Other experimental methods use stem cells applied with a skin cell gun. Researchers are also studying microcolumn grafting. This method uses needles to implant small biopsies into a wound. Additionally, devices like the DermaClose use skin anchors to pull wounds closed gradually.